Ladenburg Thalmann Financial Services’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$41K	Buy	317 +44	+16%	+$4.24K	﹤0.01%	3668
2019 Q3	$22K	Hold	273	–	–	﹤0.01%	3996
2019 Q2	$28K	Buy	273 +8	+3%	+$623	﹤0.01%	3856
2019 Q1	$19K	Hold	265	–	–	﹤0.01%	4045
2018 Q4	$11K	Buy	+265	New	+$10.6K	﹤0.01%	4237
2018 Q1	–	Sell	-273	Closed	-$5K	–	5233
2017 Q4	$5K	Hold	273	–	–	﹤0.01%	4539
2017 Q3	$3K	Hold	273	–	–	﹤0.01%	4601
2017 Q2	$1K	Hold	273	–	–	﹤0.01%	4790
2017 Q1	$1K	Hold	273	–	–	﹤0.01%	4764
2016 Q4	$1K	Hold	273	–	–	﹤0.01%	4733
2016 Q3	$2K	Hold	273	–	–	﹤0.01%	4528
2016 Q2	$1K	Hold	273	–	–	﹤0.01%	4637
2016 Q1	$6K	Hold	273	–	–	﹤0.01%	4011
2015 Q4	$9K	Buy	+273	New	+$9.64K	﹤0.01%	3749

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MRTX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Mirati Therapeutics, Inc. Common Stock (MRTX) stake by 16% in Q4 2019, buying an estimated $4.24K and bringing the position to 317 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #3668.

Ladenburg Thalmann Financial Services first reported a position in MRTX in Q4 2015 and has held it in 14 quarters since. 190 funds tracked by Wall St. Rank hold MRTX as of Q4 2019.

Ladenburg Thalmann Financial Services held 317 shares of Mirati Therapeutics, Inc. Common Stock worth $41K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 44 Mirati Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $4.24K.
Mirati Therapeutics, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3668 holding.
Ladenburg Thalmann Financial Services first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2015 and has held it in 14 quarters since.
190 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.